2011 Clinical Trials Strains Treatment 
Greencamp
FEBRUARY 17, 2019
One study from 2004 looked at cannabinoids as a treatment option for managing bowel diseases symptoms (including IBS), because of their anti-inflammatory properties, but also the ability to diminish pain levels. How to choose the best strain for IBS? Neuroendocrinology Letters; April 2008; 29(2):192-200.
The Cannigma
JUNE 23, 2022
A 2011 in vitro study examined the anti-inflammatory properties of six different cannabinoids, including CBGA. And while some are hopeful for the potential of CBGA, most experts are not yet convinced of cannabinoids as prevention or treatment of COVID infections. Pain and inflammation. Where can you buy CBGA?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 9, 2022
We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.
Cannabis Law Report
FEBRUARY 25, 2019
Syqe Medical was founded in 2011 in order to develop a measurable and repeatable method of administering medical cannabis. We like the fact that in some of its strains, the product has a psychoactive effect. If you grind them up into powder, you burst the trichoma and oxidation of the plant begins. It’s very instinctive.
The Cannigma
FEBRUARY 11, 2021
Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data.
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Cannabis products and strains with beta-caryophyllene and terpinolene.
Green Relief
MAY 12, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Cannabis products and strains with beta-caryophyllene and terpinolene.
Expert insights. Personalized for you.
96 
Let's personalize your content